Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Santalum album ointment - Santalis Healthcare

Next Previous
Search
Drug Profile

Santalum album ointment - Santalis Healthcare

Alternative Names: Albuterpenoid -Santalis Healthcare ViroXis; East Indian sandalwood oil - Santalis Healthcare; EISO - Santalis Healthcare

Latest Information Update: 29 Jan 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ViroXis
  • Developer Santalis Healthcare Corporation; ViroXis
  • Class Anti-infectives; Phytotherapies; Skin disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Warts
  • Discontinued Acne; Mycoses; Skin and soft tissue infections; Skin cancer; Wounds

Most Recent Events

  • 25 Jan 2016 ViroXis is now called Santalis Healthcare
  • 11 Jan 2016 Santalis Pharmaceuticals plans a phase III trial for Warts (In children) in USA
  • 15 Jun 2015 Santalum album ointment is still in phase II trials for Warts in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top